BAM
PFE icon

Bellevue Asset Management’s Pfizer PFE Stock Holding History

Bellevue Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.4K Buy
1,429
+11
+0.8% +$288 0.02% 212
2026
Q1 		$39.8K Sell
1,418
-74
-5% -$1.97K 0.02% 184
2025
Q4 		$37.2K Sell
1,492
-260
-15% -$6.56K 0.01% 184
2025
Q3 		$44.7K Sell
1,752
-99
-5% -$2.44K 0.02% 169
2025
Q2 		$44.9K Buy
1,851
+15
+0.8% +$350 0.02% 167
2025
Q1 		$46.5K Buy
1,836
+14
+0.8% +$366 0.03% 160
2024
Q4 		$48.3K Buy
1,822
+172
+10% +$4.67K 0.03% 160
2024
Q3 		$47.8K Sell
1,650
-240
-13% -$7K 0.02% 166
2024
Q2 		$52.9K Sell
1,890
-1,135
-38% -$31.2K 0.03% 144
2024
Q1 		$84K Sell
3,025
-21
-0.7% -$583 0.05% 108
2023
Q4 		$87.7K Sell
3,046
-167
-5% -$5.05K 0.08% 104
2023
Q3 		$107K Buy
3,213
+3
+0.1% +$106 0.07% 83
2023
Q2 		$118K Buy
3,210
+2
+0.1% +$78 0.07% 79
2023
Q1 		$131K Buy
3,208
+2
+0.1% +$86 0.09% 77
2022
Q4 		$163K Buy
3,206
+1
+0% +$48 0.13% 67
2022
Q3 		$140K Buy
3,205
+3
+0.1% +$146 0.11% 80
2022
Q2 		$169K Buy
3,202
+1
+0% +$51 0.12% 71
2022
Q1 		$167K Buy
3,201
+2
+0.1% +$104 0.1% 80
2021
Q4 		$189K Sell
3,199
-231
-7% -$11.4K 0.11% 72
2021
Q3 		$149K Buy
3,430
+1
+0% +$44 0.09% 89
2021
Q2 		$134K Sell
3,429
-398
-10% -$15.5K 0.08% 100
2021
Q1 		$139K Buy
3,827
+1,147
+43% +$40.7K 0.09% 100
2020
Q4 		$100K Sell
2,680
-793
-23% -$29.1K 0.06% 112
2020
Q3 		$121K Buy
3,473
+25
+0.7% +$877 0.08% 98
2020
Q2 		$107K Sell
3,448
-42
-1% -$1.43K 0.11% 105
2020
Q1 		$126K Buy
3,490
+172
+5% +$5.86K 0.13% 96
2019
Q4 		$123K Buy
+3,318
New +$118K 0.09% 98

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bellevue Asset Management's PFE Position: Q2 2026 in Review

Bellevue Asset Management increased its Pfizer (PFE) stake by 0.78% in Q2 2026, buying an estimated $288 and bringing the position to 1,429 shares worth $34.4K. The position accounts for 0.02% of the portfolio, ranked #212.

Bellevue Asset Management first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $189K in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bellevue Asset Management held 1,429 shares of Pfizer worth $34.4K as of Q2 2026.
  • Bellevue Asset Management bought 11 Pfizer shares in Q2 2026, an estimated $288.
  • Pfizer made up 0.02% of Bellevue Asset Management's portfolio in Q2 2026, its #212 holding.
  • Bellevue Asset Management first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Bellevue Asset Management's Pfizer position peaked at $189K in Q4 2021.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.